Bango J, Fadón P, Mata F, Rubio G, Santo-Domingo J
Servicio de Psiquiatría, Hospital Universitario La Paz, Madrid.
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998 Jul-Aug;26(4):260-3.
Ecstasy use have raised in recent years and it have been related to psychopathological symptoms. The comsumption pattern associated with psychiatric complications is unknown.
Thirty-six case reports about psychiatric complications due to ecstasy and published from 1985 to 1997 were studied.
The disorders with higher prevalence were psychosis (n = 21), panic attacks (n = 12) and depressive symptoms (n = 3). Seventy two per cent were substance abusers. Urinary drugs screening were present in 28%, only in two subjects might detect amphetamine. Men had higher MDMA doses compsumption and higher prevalence of background psychiatric disorders than women. Subjects with psychotic symptomatology had more psychiatric background, higher doses of MDMA comsumption and for a long time than individuals with depressive or panic attacks symptomatology.
The review of the case reports of psychiatric complications related to ecstasy use do not allow to conclude that ecstasy use was the main responsible factor for psychiatric symptoms. They could be related to an individual vulnerability and or to lasting of comsumption.
近年来摇头丸的使用有所增加,且与精神病理症状有关。与精神并发症相关的消费模式尚不清楚。
研究了1985年至1997年发表的36例因摇头丸导致精神并发症的病例报告。
患病率较高的疾病为精神病(n = 21)、惊恐发作(n = 12)和抑郁症状(n = 3)。72%为药物滥用者。28%进行了尿液药物筛查,仅在两名受试者中检测到安非他命。男性的摇头丸消费量高于女性,且背景精神障碍的患病率也高于女性。有精神病症状的受试者比有抑郁或惊恐发作症状的受试者有更多的精神病史、更高的摇头丸消费量且使用时间更长。
对与使用摇头丸相关的精神并发症病例报告的综述无法得出使用摇头丸是精神症状主要责任因素的结论。它们可能与个体易感性和/或消费持续时间有关。